USA - NYSE:HTB - US4378721041 - Common Stock
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 207.12M | 202.12M | 188.50M | 150.00M | 143.10M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 172.41M | 168.68M | 157.40M | 110.80M | 103.30M | |||
| Non Interest Income | 34.71M | 33.45M | 31.10M | 39.20M | 39.80M | |||
| Loan Loss Provision | 4.96M | 7.54M | 15.40M | -600.00K | -7.10M | |||
| Net Interest Income after Provision | 167.45M | 161.13M | 142.00M | 111.40M | 110.50M | |||
| Non Interest Expense | -126.81M | -124.67M | -115.90M | -105.20M | -131.20M | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 75.35M | 69.91M | 57.20M | 45.40M | 19.10M | |||
| Income Tax | 16.28M | 15.11M | 12.60M | 9.70M | 3.40M | |||
| Net Income | 58.45M | 54.26M | 44.20M | 35.30M | 15.50M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.4207 | 3.1963 | 2.8 | 2.24 | 0.94 | |||
| Non GAAP EPS | 3.49 | 3.34 | 2.85 | 2.22 | 1.17 | |||
| Statistics | ||||||||
| Profit Margin | 28.22% | 26.85% | 23.45% | 23.53% | 10.83% | |||
All data in USD